Fundraising Fox
bioTheranostics
San Diego, US · Founded 2008 · Delaware corporation · 97 employees on LinkedIn · 3 known investors
Find your way into bioTheranostics
Sign up to find every way you can get introduced to bioTheranostics
- Your email: who you already know at bioTheranostics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the bioTheranostics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Biotheranostics develops proprietary genomic assays used to support personalized disease management in oncology. The company was acquired by Hologic in February 2021.
Founders & leadership
NB
Nicholas BarthelemyExecutive
Board
DK
EB
AS
Investors · 3
Evidity Health Capitallisted by Evidity Health CapitalNew York · $5M
How we know: Evidity Health Capital's portfolio page · Not right? Tell us
HealthQuest CapitalreportedRedwood City
How we know: funding news · Not right? Tell us
MVM Life Science PartnersreportedLondon · $20M – $100M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$20M disclosed across 1 round · 2016
▶$20MraisedFeb 2016 · 4 investors · Other Health CareRule 506(b)
▶$20MraisedFeb 2016 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas BarthelemyExecutive Officer, Director, Promoter
- David KabakoffDirector
- Eric BednarskiDirector
- Alejandro SanchezDirector
- Offering amount
- $32M
- Amount sold
- $20M
- Sales commissions
- $1.6M
- Placement agents
- Piper Jaffray & Co.
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does bioTheranostics do?
- Biotheranostics develops proprietary genomic assays used to support personalized disease management in oncology. The company was acquired by Hologic in February 2021.
- Who are bioTheranostics's investors?
- bioTheranostics's investors include Evidity Health Capital, HealthQuest Capital, MVM Life Science Partners.
- How much funding has bioTheranostics raised?
- bioTheranostics has disclosed $20M raised across 1 round.
- Where is bioTheranostics headquartered?
- bioTheranostics is headquartered in San Diego, US.